As a result of SMAD4 loss, the advantage of growth for pancreatic cancer cells in the late PanIN stage (PanIN-3) is provided by nullifying the signals arbitrated by TGF-β [24]. This evidence concerns the gene SMAD4 and familial pancreatic carcinoma.